Tyrosine Kinase Inhibitors - Pipeline Insights 2017
The “Tyrosine kinase Inhibitors-Pipeline Insights 2017″ report provides a comprehensive analysis of tyrosine kinase inhibitor drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential Akt inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding, patent, and USFDA and EMA designations.View report: https://www.arizton.com/reports/pharma-pipeline-analysis/tyrosine-kinase-inhibitors-pipeline-insights-2017
It also assesses the pipeline tyrosine kinase inhibitors by monotherapy, combination products, molecule type and route of administration. In addition to analysis on active pipeline molecules, the report also provides detailed information about discontinued and dormant drugs.
The report profiles key players in developing potential tyrosine kinase drug candidates. The company profile section provides details such as company overview, business overview, financial overview, product portfolio, business strategies, and recent developments.
Scope
Provides in-depth insights about active Tyrosine kinase inhibitors pipeline drug candidates
Offers an extensive pipeline product coverage with demarcation by various stages of development from NDA filings to discovery
Provides pipeline assessment by monotherapy, combination therapy products, and route of administration
Provides comparative analysis of key marketed and pipeline Tyrosine kinase inhibitors
Includes coverage of detailed pipeline drug profiles, which include product description, chemical information, MOA, licensors and collaborators, development partner
Analyzes key players involved in clinical research and development of the Tyrosine Kinase inhibitors
Provides the coverage of key news related to Tyrosine kinase inhibitors, including major mergers and acquisitions and product development updates such as clinical trial progression updates and regulatory updates
Reasons to Buy
To gain erudite insights about the Tyrosine Kinase inhibitor pipeline landscape
To ascertain unique product development dynamics and leverage it for new target identification, drug repositioning, and precision medicine
To optimize the pipeline product portfolio in correspondence with the dynamic pharmaceutical market
To identify competitors and design strategic initiatives for drug development activities
To understand the market and choose right partners for strategic collaborations
To obtain informed updates on drug termination/drug discontinuation
Related Reports
Chimeric Antigen Receptor (CAR) T Cell Immunotherapy - Pipeline Insights 2017
View report: https://www.arizton.com/reports/pharma-pipeline-analysis/chimeric-antigen-receptor-car-t-cell-immunotherapy-pipeline-insights-2017
Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017
https://www.arizton.com/reports/pharma-pipeline-analysis/histone-deacetylase-hdac-inhibitors-pipeline-insights
About Arizton
Arizton – Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize foolproof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including –Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Arizton Advisory & Intelligence
Chicago, Illinois, 60605
Mail: enquiry@arizton.com
Call: +1-312-465-7864
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tyrosine Kinase Inhibitors - Pipeline Insights 2017 here
News-ID: 721718 • Views: …
More Releases from Arizton Advisory & Intelligence
The US Data Center Construction Market Investment to Reach $47.72 Billion by 202 …
According to Arizton's latest research report, the U.S. data center construction market is growing at a CAGR of 11.69% during 2023-2029.
To Know More, Click: https://www.arizton.com/market-reports/united-states-data-center-construction-market-2024
The US data center construction market is witnessing robust growth, fueled by surging demand for data storage and processing capabilities. Major players across tech, real estate, and infrastructure sectors are investing significantly in building and upgrading data centers. This demand surge is propelled by…
Exclusive Focus Insight Report by Arizton Predicts, the US Pool Maintenance and …
According to Arizton's latest focus research report, the US pool maintenance and cleaning service market is growing at a CAGR of 4.17% during 2023-2029.
To Know More, Click: https://www.focusreports.store/report/us-pool-maintenance-and-cleaning-services-market
The market is growing significantly due to advances in the pool technology, shift toward sustainability practices, rising popularity of subscription-based pool services, growing awareness of chemical balancing for above-ground pools, the growing demand for pool opening and closing services, the increasing demand…
The US Neonatal Incubators Market to Reach $121.11 Million by 2029 - Exclusive F …
According to Arizton's latest focus insight report, the US Neonatal incubators market is growing at a CAGR of 3.57% during 2023-2029.
To Know More, Click: https://www.focusreports.store/report/us-neonatal-incubators-market
The infant incubator market is highly fragmented, with many producers in the US. To meet the surging consumer demand and expand their customer base, these companies are implementing various tactics such as mergers & acquisitions, partnerships & collaborations, and new product launches. Owing to the…
The US Sleep Supplements Market to Reach $1.45 Billion by 2029 - Exclusive Focus …
According to Arizton's latest research report, the US sleep supplements market is growing at a CAGR of 5.97% during 2023-2029.
To Know More, Download the Free Sample Report: https://www.focusreports.store/report/us-sleep-supplements-market
The US sleep supplements market is growing significantly due to a surge in online sales and increasing demand for plant-based options. Lifestyle factors such as stress, irregular sleep patterns, and changing demographics, notably an aging population and health-conscious millennials, are driving this…
More Releases for Tyrosine
Global Tyrosine Market 2015-2025 | Growing Opportunities and Trends in Tyrosine …
The Market Research Store has added the latest report on the Global Tyrosine Market which includes the historical data from 2015 to 2019 and has also precisely forecasted data from 2020 to 2025. The global Tyrosine market anticipates to showcase market value in terms of USD Million during the forecast period 2020 to 2025. According the research analyst the market will witness a steady growth during the coming years.
Get Sample…
Tyrosine Kinase Inhibitors - Pipeline Insights 2017
The “Tyrosine kinase Inhibitors-Pipeline Insights 2017″ report provides a comprehensive analysis of tyrosine kinase inhibitor drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential Akt inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding, patent,…
Tyrosine Kinase Inhibitors - Pipeline Insights 2017
The “Tyrosine kinase Inhibitors-Pipeline Insights 2017″ report provides a comprehensive analysis of tyrosine kinase inhibitor drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential Akt inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding, patent,…
Research Study on Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyro …
Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyrosine Phosphatase 1B or Protein Tyrosine Phosphatase Placental or PTP1B or PTPN1 or EC 3.1.3.48) comprises nearly 15 molecules. Of these, nearly 9 are developed by companies and the rest are developed by universities. Many molecules developed by companies are in various stages. The situation is more or less similar for molecules developed by universities. A new research study added to the…
Research Study on Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyro …
Tyrosine Protein Phosphatase Non Receptor Type 1 (Protein Tyrosine Phosphatase 1B or Protein Tyrosine Phosphatase Placental or PTP1B or PTPN1 or EC 3.1.3.48) comprises nearly 15 molecules. Of these, nearly 9 are developed by companies and the rest are developed by universities. Many molecules developed by companies are in various stages. The situation is more or less similar for molecules developed by universities. A new research study added to the…
Tyrosine Market Trends and 2022 Forecast
ReportsWeb.com has announced the addition of the “United State Tyrosine 2022 Market Research Report” The report focuses on United State major leading players with information such as company profiles, product picture and specification.
United States Tyrosine market competition by top manufacturers/players, with Tyrosine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Ajinomoto
Evonik
KYOWA
Tianjin Tianan Pharmaceuticals
Hubei Bafeng Pharmaceutical
Jinghai Amino Acid
JIRONG PHARM
ChuyuanGroup
Siwei Amino Acid
SHINE STAR (HUBEI) BLOLOGICAL
For…